Literature DB >> 28496603

Atrial Fibrillation: a Patient's Guide to Understanding Drug Therapy.

Ragini S Bhakta1.   

Abstract

Entities:  

Year:  2008        PMID： 28496603      PMCID： PMC5398810          DOI： 10.4022/jafib.146

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


× No keyword cloud information.
  9 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.

Authors:  S H Hohnloser; K H Kuck; J Lilienthal
Journal:  Lancet       Date:  2000-11-25       Impact factor: 79.321

4.  ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation).

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-08-15       Impact factor: 24.094

5.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

6.  Comparison of the impact of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial on prescribing patterns: a time-series analysis.

Authors:  Niteesh K Choudhry; Brandon Zagorski; Jerry Avorn; Raisa Levin; Kathy Sykora; Andreas Laupacis; Muhammad Mamdani
Journal:  Ann Pharmacother       Date:  2008-09-30       Impact factor: 3.154

7.  Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Authors:  Jörg Carlsson; Sinisa Miketic; Jürgen Windeler; Alessandro Cuneo; Sebastian Haun; Stefan Micus; Sabine Walter; Ulrich Tebbe
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

8.  Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.

Authors:  Grzegorz Opolski; Adam Torbicki; Dariusz A Kosior; Marcin Szulc; Beata Wozakowska-Kaplon; Piotr Kolodziej; Piotr Achremczyk
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

9.  Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.

Authors:  Dana E King; Lori M Dickerson; Jonathan L Sack
Journal:  Am Fam Physician       Date:  2002-07-15       Impact factor: 3.292
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.